Healx, a U.K. startup using AI to discover new drugs for rare diseases, has raised $47 million in a Series C round of funding co-led by Europe’s Atomico and Silicon Valley-based R42. The company also said that it has received regulatory clearance to start Phase 2 clinical trials for a new drug in the U.S. […]

© 2024 TechCrunch. All rights reserved. For personal use only.

Related

UK chip incubator startups secure over £10M in funding

EU greenlights HPE’s $14B Juniper Networks acquisition

Healx, an AI-enabled drug discovery platform for rare diseases, raises $47M

Did Boyce Watkins Throw Shade At Gilbert Arenas For Proposing To Melli Monaco?

respect

हमारा रिश्ता नही हो रहा है अफवाह ना फैलाये || pahadi lifestyle vlog

Amir and Family Build a Stunning Platform in Front of Water Tankers

Axle Energy’s sprint to decarbonize the grid lights up with $9M seed led by Accel

Zuckerberg says Meta will need 10x more computing power to train Llama 4 than Llama 3

OpenAI pledges to give U.S. AI Safety Institute early access to its next model

Blonde girl arriving Hotel de Paris in Lamborghini #billionaire #monaco #luxury #trending #lifestyle

Den sværeste video jeg har lavet ! - Toyota Supra